Call us now

Call us free and speak with a member of our client relationship team who will be happy to help.

0808 271 4668

Lines are open from 9am to 7pm Monday to Friday and 10am to 5pm on a Saturday.

or

Arrange callback

Let us know a suitable time for us to call you back.

 
or

Thank You

Thank you for contacting Shoosmiths Serious Injury. Your enquiry is important to us. A dedicated member from our client relationship team will be in touch with you shortly.

Message us

If you would prefer to write to us, you can send us a message by clicking below and we will get back to you Send us a message

Dan O'Keeffe

Legal Director

Medical Negligence


Dan is a Legal Director and clinical negligence solicitor, acting for Claimants in complex cases, all over the country.

Dan has a specialist interest in spinal injury cases, in particular Cauda Equina Syndrome claims.

Prior to joining Shoosmiths, Dan was a Director at Moosa-Duke Solicitors and before that he worked at Russell-Cooke in London. Since qualifying, Dan has exclusively represented claimants in high value, complex, novel and high profile personal injury and medical negligence cases. 

Dan has always been an enthusiastic contributor to his local legal community. Dan has served in many voluntary roles, including as Editor of the Leicestershire Law Society magazine and as President of the Leicestershire Medico-Legal Society. In 2021 Dan was awarded the accolade of Solicitor of the Year by the Leicestershire Law Society.

Throughout his career, Dan has always been an active member of the Association of Personal Injury Lawyers (APIL), previously being Secretary for the Product Liability Special Interest Group and Co-ordinator for the East Midlands Group.

Dan acted for the claimant in the case of X v University Hospitals of Leicester NHS Trust (2019) where there was a negligent delay in diagnosing and treating Cauda Equina Syndrome. Dan recovered a 7 figure sum for the claimant, following a three week trial. In light of his expertise in Cauda Equina Syndrome cases, Dan was invited to contribute to a new Cauda Equina Syndrome pathway, being considered by three hospital trusts.

 

Dan O'Keeffe's insights